Carl Heinrich Bruhn is an experienced entrepreneur with a strong track record in building and leading companies across multiple sectors, including agriculture, food, energy, minerals, and life sciences. He is the Founder and Chief Executive Officer of CHB Investment Holding GmbH, which he established in 2004. Under his leadership, the company has developed a diversified international investment portfolio that promotes sustainable growth and innovation in key industries shaping the global economy.

In addition to his work at CHB Investment Holding, he was the Founder and former CEO of Amatheon Agri Holdings, a vertically integrated agribusiness and food company that he led from 2011 to 2023. Through Amatheon Agri, he advanced large-scale agricultural production and value-chain development across Sub-Saharan Africa, fostering responsible investment and sustainable practices within the agricultural sector.

Before founding his own company, Bruhn held several senior management positions in the dairy and food industries. From 2002 to 2004, he served as CEO of the Sachsen Milch Group, where he oversaw significant growth and operational transformation. Earlier in his career, between 1993 and 2002, he spent nearly a decade with Nordmilch, one of Germany's largest dairy cooperatives, where he held multiple leadership roles and gained extensive experience in industrial operations, supply chain management, and international business strategy.

Prof. Dr. Christian Kühn is one of the leading clinicians and researchers at Hannover Medical School, where he combines medical excellence with pioneering work in infection control and cardiovascular medicine. He currently serves as Director of the Center for Phage Therapy, a state-of-the-art research and clinical institute dedicated to developing bacteriophage-based treatments as an alternative to antibiotics. Under his leadership, the center has evolved into a hub for innovative approaches to combating antibiotic resistance and improving patient outcomes through personalized therapeutic strategies.

In addition to his role as Director, Prof. Dr. Kühn serves as Senior Consultant (Erster Oberarzt) at the Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery at Hannover Medical School. In this position, he plays a key role in advancing surgical practices and mentoring the next generation of physicians. His clinical expertise spans complex surgical procedures and interdisciplinary collaboration in transplantation and vascular medicine.

A testament to his dedication to academic leadership and institutional governance, Prof. Dr. Kühn also serves as Deputy Senator of Hannover Medical School, representing the university's professors. In this capacity, he contributes to shaping the institution's research policy, promoting excellence in science, and strengthening the integration of innovation and clinical care.

Sven Suhr is a dynamic executive with a broad background in energy management, sustainable technologies, and corporate development. He currently serves as Managing Director of both GETEC Corp GmbH and GETEC Green Energy GmbH, where he plays a leading role in implementing the group's strategy for renewable energy solutions and sustainable infrastructure projects. His work focuses on advancing green energy initiatives and driving innovation within the European energy market.

In addition to his executive roles at GETEC, Suhr serves as Head of Mergers & Acquisitions at GETEC Energie Holding GmbH, where he is responsible for strategic investments, corporate partnerships, and portfolio expansion. His expertise in structuring complex transactions and identifying growth opportunities has been instrumental in the group's ongoing expansion across the energy and technology sectors.

Beyond his work with GETEC, Suhr also holds managing director positions at Neoscan Solutions GmbH and Elfolion GmbH, contributing to the development and commercialization of advanced technologies. Earlier in his career, from 2014 to 2016, he worked as Manager of Business Development at Delta Organic Corps, where he gained valuable experience in sustainability-oriented business models and market development.

Throughout his career, Sven Suhr has demonstrated a strong commitment to innovation, strategic growth, and environmental responsibility, consistently bridging corporate leadership with a forward-looking vision for the global energy transition.

Prof. Dr. Heinz-Walter Große is an accomplished leader with a distinguished career spanning several decades in the healthcare and investment sectors. He currently serves as Chairman of the Advisory Board of CHB Investment Holding GmbH, where he brings extensive leadership experience and strategic expertise to the role.

From 2011 to 2019, he was Chief Executive Officer of B. Braun Melsungen AG, one of the world's leading manufacturers of medical and pharmaceutical products. During his long tenure at B. Braun, which began in 2005 when he joined the company's Executive Board, Prof. Dr. Große held numerous senior positions including CEO of B. Braun Austria and Director of B. Braun of America Inc., and made significant contributions to the company's global growth and innovation.

In addition to his work at B. Braun, he has held influential roles in other organizations. From 2018 to 2023, he served as Chairman of the Supervisory Board of Aesculap AG, a B. Braun subsidiary specializing in surgical technologies. From 2015 to 2023, he was President of SAFRI, the Sub-Saharan Africa Initiative of German Business, where he actively promoted economic cooperation and sustainable development between Germany and Sub-Saharan Africa.

Prof. Dr. Axel Haverich is a distinguished cardiac surgeon and medical innovator whose career has had a profound impact on cardiovascular medicine and regenerative research. From 1996 to 2023, he served at Hannover Medical School, where he led groundbreaking clinical and academic work in the field of cardiac and thoracic surgery. Under his leadership, the institution evolved into a global center of excellence for cardiovascular transplantation and tissue engineering.

In addition to his tenure at Hannover Medical School, Prof. Dr. Haverich has held several prominent positions in Germany's academic and scientific community. From 2010 to 2011, he served as President of the German Society for Surgery, demonstrating his commitment to advancing surgical science and fostering interdisciplinary collaboration. From 2012 to 2018, he was a member of the University Council of Leibniz University Hannover, contributing his expertise to university governance and research development.

As a pioneer of biomedical innovation, Prof. Dr. Haverich has co-founded several institutions and companies dedicated to advancing implant technology and regenerative medicine. He is a co-founder of NIFE Hannover, the Lower Saxony Centre for Implant Research, which bridges medical research with engineering and material sciences. In 2008, he co-founded Corlife Inc., a biotechnology company specializing in tissue-engineered heart valves. Continuing his entrepreneurial vision, he co-founded REBIRTH active Inc. in 2021, driving the translation of regenerative therapies from research into clinical practice.